Contractor
INTERNATIONAL AIDS VACCINE INITIATIVE INC.
- UEI
- ZEJBC8JQM3P5
- Parent UEI
- ZEJBC8JQM3P5
- Resolved by
- uei
- Confidence
- 1.000
Active from Apr 30, 2026 to Jul 20, 2026.
Recent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 75A50121C00077 THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN | Department of Health and Human Services | NY | Jul 20, 2026 | $95,592,504 |
| 75N93022F00001 EO 14398, CGMP MANUFACTURE, FILL-FINISH, RELEASE, ANALYTICAL AND STABILITY TESTING AND STABILITY PROGRAM OF A NANOPARTICLE BASED HIV ENVELOPE VACCINE | Department of Health and Human Services | NY | Jun 30, 2026 | $8,398,301 |
| 75N93018F00002 1800010I INTERNATIONAL AIDS VACCINE INITIATIVE; MANUFACTURE OF HUMAN FLU CHALLENGE MATERIAL | Department of Health and Human Services | NY | May 13, 2026 | $4,151,337 |
| 75N93019F00131 1800010I INTERNATIONAL AIDS VACCINE INITIATIVE; OPTION 2 FY 21 $666,400 | Department of Health and Human Services | NY | Apr 30, 2026 | $1,753,724 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier ZEJBC8JQM3P5, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Aug 10, 2026.